Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the
efficacy and safety of WPV01 in patients with mild/moderate COVID-19 infection